Your browser version may not work well with NCBI's Web applications. More information here...
1: Science. 1995 Nov 17;270(5239):1197-9.
Related Articles, Links
Click here to read
Comment in:
Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine.

Tsai CC, Follis KE, Sabo A, Beck TW, Grant RF, Bischofberger N, Benveniste RE, Black R.

University of Washington Regional Primate Research Center, Seattle 98195, USA.

The efficacy of pre- and postexposure treatment with the antiviral compound (R)-9-(2-phosphonylmethoxypropyl)adenine (PMPA) was tested against simian immunodeficiency virus (SIV) in macaques as a model for human immunodeficiency virus (HIV). PMPA was administered subcutaneously once daily beginning either 48 hours before, 4 hours after, or 24 hours after virus inoculation. Treatment continued for 4 weeks and the virologic, immunologic, and clinical status of the macaques was monitored for up to 56 weeks. PMPA prevented SIV infection in all macaques without toxicity, whereas all control macaques became infected. These results suggest a potential role for PMPA prophylaxis against early HIV infection in cases of known exposure.

Publication Types:
PMID: 7502044 [PubMed - indexed for MEDLINE]